ASKA Pharmaceutical Holdings CO., Ltd.TSE 4886

あすか製薬ホールディングス株式会社 · Pharmaceutical · FY ends Mar

Share price at FY-end
¥2,360
FY ending Mar 2026
Market cap at FY-end
¥67.9B
Dividend per share
¥60.0
Avg. director pay
—
Internal directors

Top 10 shareholders

#ShareholderSharesStakeValueDividends
1 日本マスタートラスト信託銀行株式会社 2,670,000 9.40% ¥6.3B ¥160M
2 NIPPON ACTIVE VALUE FUND PLC 2,399,000 8.44% ¥5.7B ¥144M
3 Takeda Pharmaceutical Co., Ltd. 2,204,000 7.76% ¥5.2B ¥132M
4 Zeria Shinyaku Kogyo Co., Ltd. 1,877,000 6.61% ¥4.4B ¥113M
5 STATE STREET BANK AND TRUST COMPANY 505103 1,138,000 4.00% ¥2.7B ¥68.3M
6 株式会社三菱UFJ銀行 1,100,000 3.87% ¥2.6B ¥66.0M
7 NAVF Select LLC 848,000 2.98% ¥2.0B ¥50.9M
8 NOMURA PB NOMINEES LIMITED OMNIBUS MARGIN 789,000 2.78% ¥1.9B ¥47.3M
9 Takashi Yamaguchi 707,000 2.49% ¥1.7B ¥42.4M
10 CACEIS BANK,LUXEMBOURG BRANCH/AIF CLIENTS ASSETS 593,000 2.08% ¥1.4B ¥35.6M

Officers' holdings and pay

NameTitleSharesValuePay
Takashi Yamaguchi Representative Director 707,000 ¥1.7B —
Soudai Yamaguchi Representative Director 144,000 ¥340M —
丸尾 篤嗣 Representative Director 49,000 ¥116M —
森 麻衣子 Director 16,000 ¥37.8M —
山口 文豊 Director 9,000 ¥21.2M —
粟林 稔 Director — — —
榎戸 康二 Director — — —
苅田 香苗 Director — — —
加藤 聖子 Director — — —
軍司 国弘 Full-time Audit & Supervisory Board Member 12,000 ¥28.3M —
知久 一博 Full-time Audit & Supervisory Board Member 5,000 ¥11.8M —
木村 高男 Audit & Supervisory Board Member — — —
山下 功起 Audit & Supervisory Board Member — — —

Pay is shown only for officers whose pay of ¥100 million or more is disclosed individually.

Per-share data by fiscal year

Fiscal yearPriceEPSP/EDividendShares issued
FY ending Mar 2026 ¥2,360 ¥191.12 12.3x ¥60.0 28,763,199
FY ending Mar 2025 ¥2,303 ¥179.95 12.8x ¥55.0 28,763,199
FY ending Mar 2024 ¥2,220 ¥266.51 8.3x ¥40.0 30,563,199
FY ending Mar 2023 ¥1,189 ¥150.08 7.9x ¥16.0 30,563,199
FY ending Mar 2022 ¥1,263 ¥151.22 8.3x ¥15.0 30,563,199
Source: annual securities reports on EDINET. Values are estimates. Methodology